Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vesiflo is a privately held U.S. medical device company focused on bladder management and female pelvic health. Its lead commercial product is the inFlow urinary prosthesis, an FDA-approved intraurethral valve-pump designed for women with chronic urinary retention and impaired detrusor contractility as an alternative to urinary catheters. The company also is developing the Guardian remote monitoring and clinical information system, a digital health program intended to support patients and clinicians managing chronic urinary retention in the community. Vesiflo positions its products around improved quality of life, reduced infection risk relative to catheter-based management, and more dignified bladder emptying.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vesiflo.